BWX Technologies reported a robust third quarter for 2025, achieving 12% organic revenue growth and strong profitability driven by increased demand in government and commercial operations.
- Revenue reached $866 million, with adjusted EBITDA growing by approximately 20%.
- Book-to-bill ratio of 2.6, leading to a record backlog of $7.4 billion, up 23% sequentially and 119% year-over-year.
- Significant contracts awarded include a $1.5 billion uranium enrichment initiative and a $1.6 billion supply contract for high-purity depleted uranium, highlighting government market strength.
- Commercial operations revenue surged 122%, bolstered by acquisitions and growth in medical isotopes and nuclear power sectors.
- Strong outlook for 2026, with expectations to exceed medium-term financial targets, driven by operational excellence and expansion in key markets.
Community Discussion